Abstract:ABSTRACT A guide RNA (gRNA) directs the function of a CRISPR protein effector to a target gene of choice, providing a versatile programmable platform for engineering diverse modes of synthetic regulation (edit, silence, induce, bind). However, the fact that gRNAs are constitutively active places limitations on the ability to confine gRNA activity to a desired location and time. To achieve programmable control over the scope of gRNA activity, here we apply principles from dynamic RNA nanotechnology to engineer conditional guide RNAs (cgRNAs) whose activity is dependent on the presence or absence of an RNA trigger. These cgRNAs are programmable at two levels, with the trigger-binding sequence controlling the scope of the effector activity and the target-binding sequence determining the subject of the effector activity. We demonstrate molecular mechanisms for both constitutively active cgRNAs that are conditionally inactivated by an RNA trigger (ON→OFF logic) and constitutively inactive cgRNAs that are conditionally activated by an RNA trigger (OFF→ON logic). For each mechanism, automated sequence design is performed using the reaction pathway designer within NUPACK to design an orthogonal library of three cgRNAs that respond to different RNA triggers. In E. coli expressing cgRNAs, triggers, and silencing dCas9 as the protein effector, we observe programmable conditional gene silencing with a median dynamic range of ≈6-fold for an ON→OFF “terminator switch” mechanism, ≈15-fold for an ON→OFF “splinted switch” mechanism, and ≈3.6-fold for an OFF→ON “toehold switch” mechanism; the median crosstalk within each cgRNA library is <2%, <2%, and ≈20% for the three mechanisms. By providing programmable control over both the scope and target of protein effector function, cgRNA regulators offer a promising platform for synthetic biology.

Chemically programed nucleic condensates for spatiotemporal control of mammalian gene expression

Programmable synthetic biomolecular condensates for cellular control

A synthetic transcription platform for programmable gene expression in mammalian cells

A tunable, rapid, and precise drug control of protein expression by combining transcriptional and post-translational regulation systems

Small-molecule inducible transcriptional control in mammalian cells

Engineered poly(A)-surrogates for translational regulation and therapeutic biocomputation in mammalian cells

A Chemical CRISPR off Switch Efficiently Controls Gene Editing

Engineering Material Properties of Transcription Factor Condensates to Control Gene Expression in Mammalian Cells and Mice

Orthogonal inducible control of Cas13 circuits enables programmable RNA regulation in mammalian cells

Conditional guide RNA through two intermediate hairpins for programmable CRISPR/Cas9 function: building regulatory connections between endogenous RNA expressions

Co-transcriptional production of programmable RNA condensates and synthetic organelles

De novo engineering of programmable and multi-functional biomolecular condensates for controlled biosynthesis

Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system

Synthetic Dual-Input Mammalian Genetic Circuits Enable Tunable and Stringent Transcription Control by Chemical and Light

Inducible CRISPR-dCas9 Transcriptional Systems for Sensing and Genome Regulation.

Conditional Guide RNAs: Programmable Conditional Regulation of CRISPR/Cas Function in Bacteria via Dynamic RNA Nanotechnology

Employing Ph-Responsive RNA Triplex to Control CRISPR/Cas9-mediated Gene Manipulation in Mammalian Cells

Programmable Transcriptional Modulation with a Structured RNA-Mediated CRISPR-dCas9 Complex

Synthetic protein condensates that recruit and release protein activity in living cells

Cell‐Specific Control of Mammalian Gene Expression Using DNA Repair Inducible Ribozyme Switches

Establishing Artificial Gene Connections Through RNA Displacement–assembly-Controlled CRISPR/Cas9 Function